It’s hard not to start asking the question: Are we being played?
by Adam Taggart
Chris Martenson’s Peak Prosperity
Following yesterday’s pimping of Gilead Science’s antiviral drug remdesivir on scant and suspect results, it’s hard not to start asking the question: Are we being played?
We’ve argued in several past videos that there is ample enough evidence that hydroxychloroquine shows enough promise in reducing/treating covid-19 that further research is merited. Instead, the drug is being demonized in the media.
That doesn’t make a lot of sense to us. But, hey, maybe there’s a good reason that a cheap widely-available treatment that has been administered hundreds of millions of times over the past 70 years, making it one of the most medically-delivered drugs in history, is suddenly being labelled “unsafe”?
But much more maddening is that remdesivir has suddenly been promoted to “standard of care” status despite its spotty and unproven track record.
Could that have anything to do with the fact that 9 of the 50 doctors on the NIH panel setting its covid-19 treatment guidelines work for Gilead Sciences?